Trust Co. of Toledo NA OH Sells 3,330 Shares of Baxter International Inc. (NYSE:BAX)

Trust Co. of Toledo NA OH lowered its holdings in shares of Baxter International Inc. (NYSE:BAX) by 13.7% in the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 21,045 shares of the medical instruments supplier’s stock after selling 3,330 shares during the period. Trust Co. of Toledo NA OH’s holdings in Baxter International were worth $704,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently modified their holdings of the business. Versant Capital Management Inc grew its position in shares of Baxter International by 974.2% in the 2nd quarter. Versant Capital Management Inc now owns 1,332 shares of the medical instruments supplier’s stock valued at $45,000 after buying an additional 1,208 shares during the last quarter. DNB Asset Management AS grew its position in shares of Baxter International by 1.8% in the 2nd quarter. DNB Asset Management AS now owns 80,451 shares of the medical instruments supplier’s stock valued at $2,691,000 after buying an additional 1,454 shares during the last quarter. Massmutual Trust Co. FSB ADV grew its position in shares of Baxter International by 23.0% in the 2nd quarter. Massmutual Trust Co. FSB ADV now owns 2,544 shares of the medical instruments supplier’s stock valued at $85,000 after buying an additional 475 shares during the last quarter. Birmingham Capital Management Co. Inc. AL grew its position in shares of Baxter International by 6.1% in the 1st quarter. Birmingham Capital Management Co. Inc. AL now owns 13,885 shares of the medical instruments supplier’s stock valued at $593,000 after buying an additional 800 shares during the last quarter. Finally, Garde Capital Inc. bought a new stake in shares of Baxter International in the 1st quarter valued at about $101,000. Institutional investors and hedge funds own 90.19% of the company’s stock.

Baxter International Stock Performance

Shares of BAX traded up $2.29 on Tuesday, reaching $36.93. 11,776,747 shares of the company’s stock traded hands, compared to its average volume of 4,263,346. The company has a current ratio of 1.48, a quick ratio of 1.01 and a debt-to-equity ratio of 1.35. The stock has a market cap of $18.82 billion, a PE ratio of 7.18, a PEG ratio of 1.88 and a beta of 0.57. The stock’s 50 day simple moving average is $34.26 and its two-hundred day simple moving average is $37.94. Baxter International Inc. has a 52-week low of $31.01 and a 52-week high of $44.31.

Baxter International Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, October 1st. Investors of record on Friday, August 30th will be given a dividend of $0.29 per share. This represents a $1.16 dividend on an annualized basis and a dividend yield of 3.14%. The ex-dividend date of this dividend is Friday, August 30th. Baxter International’s payout ratio is 22.31%.

Wall Street Analysts Forecast Growth

BAX has been the topic of several research analyst reports. Morgan Stanley lowered Baxter International from an “equal weight” rating to an “underweight” rating and cut their target price for the company from $39.00 to $30.00 in a research report on Monday, July 15th. TD Cowen lowered Baxter International from a “buy” rating to a “hold” rating and set a $40.00 target price on the stock. in a research report on Friday, May 10th. StockNews.com upgraded Baxter International from a “hold” rating to a “buy” rating in a research report on Thursday, August 1st. Evercore ISI cut their target price on Baxter International from $46.00 to $45.00 and set an “outperform” rating on the stock in a research report on Tuesday, July 2nd. Finally, The Goldman Sachs Group began coverage on Baxter International in a research report on Thursday, May 30th. They set a “neutral” rating and a $36.00 target price on the stock. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $41.70.

About Baxter International

Baxter International Inc, through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories.